{"id":965225,"date":"2026-05-20T09:24:56","date_gmt":"2026-05-20T13:24:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/"},"modified":"2026-05-20T09:24:56","modified_gmt":"2026-05-20T13:24:56","slug":"polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/","title":{"rendered":"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>PETACH TIKVA, Israel, May  20, 2026  (GLOBE NEWSWIRE) &#8212; PolyPid Ltd. (Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that the Company\u2019s management will participate in investor meetings at the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday, May 28, 2026, at the Depot Renaissance Hotel in Minneapolis, MN.<\/p>\n<p>Investors interested in meeting with PolyPid should contact their Craig Hallum representative directly.<\/p>\n<p>\n        <b>About PolyPid<br \/><\/b>PolyPid Ltd. (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w6_-NCycslPxZ8nOuC_tFSKfPIjWlxt_lDI8sNvRZqbP3w_WpLUGmQnFwUfS0UrY82kbhEL5rF60QAtRxcSVSylKBVZVr8eUYoButRspu-w7CwCbkgrx-JspClnoytK3YSZG-2L4ECshqBNG4thGGVlp9odp1J9JiCh_SDF4PEW7QehBymSwGZg9gOzGfi9Qf6WOPInDYOLmm6cQwHS0ozu3Ex-O4iu_9PG-1wx-0toMrEBN1c90cc_FE30lWcsPiJYQgl7xx670v7xaS3zpTbJGvdt-6tfmatt8RFZ1N1EEQYK7tAJ7gybF9FOP7ql-bc0a9Kv32RNpLsT1JnD3xUyAISGGQt05XZBzhk3RhYQOox9hkN7zhHHY9CT51xQNik--xWQrKyz5OIyJBXapOktDqa64xOP4e_eBYfcKJlbxUHcKYx_3Z6YsJJPqIQyhiExyClFVV5v29EPMmoh6W89rTnc3Q_YQpVHufZhfvjjSZNpegM3QjCF7IY2woP859kE3tsjnHcE5OOKVbWuVSHhKCr1wYkIIjNE7M_g2DzBv9Jd56IlRXaZTu10Pb1RW39UAoNApzVFHsqegn4xiDt60ePSs45yprNsF1AQBKyZyjf70A5INaKUGrQxGdn15q_MFGOYNoedTM9kAVMCgAtSbbqvNV0yTYHT5Eg8KMIbpCPStJETrRqP6f_i8unMdnmBMAlCYvknXfEuU79vVLLd20AjpGap7zS0w81RzF6H5gw3DHeYaA2tPI4ayPxw8t3A9MfaVxalqw9no2sFr-0iNUOqNOei_4P6FWM6T0oZv1NMElE5AE4HAoCYpPPYD17CPepJzR_vZ3P2suzMS-5c6071XyPI6XurCkr8tc8QznL7HOgeldPDkd7GwnubjncXcu2-j7vt-0Tue06EfLuVi-nWtibVuELLK_FPdhAYoZPFSF9wOR9wlKHCflY1KCFQAHtI49tcB8yzPoqZQUqoa-ogJ0-_lrg_2hnsfT2oMkhuK7WDdWKyoG-LIWlnzKtMrx9am-fWTG_5JuYig3kXgd1gx9Vcq1TgSoO5WVjjjC9BFVoEdA1VMikeE6iv4MKJIuUbfNOPM6CBo7n-dEyYY2oLkLe-EMhGEKHBgBmcgd0sglJEa3BZN8hm8Kf091eqaAgW7Nt3emQd7wtUWegemkdUzBYLz2cBH-24JaWrheTl7JIdXnXsDUnnRbW9Wd4iBm8OrdFMUB0xCB7btLbM3Cmd6PQsMKter86bYxA-vcQ2ELmfpLqj3a5wZGxC-Pne9gFr-Ai4mA3jm_QRdjTV0LQtZiXCuJPkEWb7zZpaqhPkgzYggTB_o2nrfgSY-SS93U0kKQ1vfdkeRq6nNJ0jN3Jx9NBhLzDvbK9okzahovNtPmayfHwUqPAZv2emVOO1BFGIcxmv7vbkMnxabFvq8oFxJUFDwaxqSvN5Mu1ZhWSaZXyFY1UiPj7ZszIGsdTkpZgtpUTg8gQDItFPAraU9nwFkQwxO5gGShv0bIZZg3lUadLOUG1uKXJ-GU5g57ysSWgHvOoaAfhJ-aDa2KA0WUj17BT48UO1WEqI7dqtv6aLzReaimN2a1FTRu8TN7J6xgzVufGWGirKJYrW6gg==\" rel=\"nofollow\" target=\"_blank\">PYPD<\/a>) is an innovative biopharmaceutical company dedicated to elevating treatment effectiveness, right where care begins. The Company develops long-acting, controlled-release drugs designed to deliver therapy precisely at the site of care, addressing critical unmet medical needs across a wide and diverse pipeline spanning surgical care, metabolic diseases, and beyond. PolyPid\u2019s lead product, D-PLEX\u2081\u2080\u2080, successfully met its primary and all key secondary endpoints in the landmark Phase 3 SHIELD II trial for the prevention of surgical site infections. Guided by a commitment to precision and innovation, PolyPid is redefining how therapies perform and raise the standard of patient care. For additional Company information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ceDdFFadP_FQ6as5sLOHqZOafM0IZYuQ8WNLkneoVO1_xEZ7IEkn8XCT62l1B9vVMomGDIHsdvAM4odS1HMy5xDiYpb1FD0tH8BL3-XqK_A=\" rel=\"nofollow\" target=\"_blank\">http:\/\/www.polypid.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TS_D6eo2Nh5089Lsg3heEfrS3t8d4ZqCJYt5lepCKq3YZHV5Ah3pQ0bXidTZ6PZn5otgEbJVCSFlAGu8ovKIow==\" rel=\"nofollow\" target=\"_blank\">Twitter (X)<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NkArAh7nsFS0XhASOQyapPSs4WmFH03J06HM3otohj3L7E6mSsaAZZhP1BCSk15nGKDDyPtmDoNZPp5pQDEibLrIQvZIhMkTho4DvBdmJZE=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <b>Company Contact:<\/b><br \/>\n        <br \/>PolyPid Ltd.<br \/>Ori Warshavsky<br \/>908-858-5995<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i6Qyg1agqHByD3jnoywmxOtJU_GnJPwGvLiLWtEhe2xMVOY8wS1DWr__lfOHgfnIYLqGdIIJ1zsCKdvdaRZi8w==\" rel=\"nofollow\" target=\"_blank\">IR@Polypid.com<\/a><\/p>\n<p>\n        <b>Investor Relations Contact:<\/b><br \/>\n        <br \/>Arx Investor Relations<br \/>North American Equities Desk<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QtoRwr4qEK7j4Nj7NC-nyzMsQpx4YiCrwOFz2E4jk6MRU1rCBpVgY6t1hMEcSTCsTjCwMXtN3smHW92GraVT4buKwrVQfkn8LYL4iJm-iuY=\" rel=\"nofollow\" target=\"_blank\">polypid@arxhq.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjEzZTZmZTEtZmM2Mi00OTg3LTgzNTctZmFhODVkMzk1MDE0LTEwMjgxOTEtMjAyNi0wNS0yMC1lbg==\/tiny\/PolyPid-Ltd-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PETACH TIKVA, Israel, May 20, 2026 (GLOBE NEWSWIRE) &#8212; PolyPid Ltd. (Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that the Company\u2019s management will participate in investor meetings at the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday, May 28, 2026, at the Depot Renaissance Hotel in Minneapolis, MN. Investors interested in meeting with PolyPid should contact their Craig Hallum representative directly. About PolyPidPolyPid Ltd. (Nasdaq: PYPD) is an innovative biopharmaceutical company dedicated to elevating treatment effectiveness, right where care begins. The Company develops long-acting, controlled-release drugs designed to deliver therapy precisely at the site of care, addressing critical unmet medical needs across &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-965225","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PETACH TIKVA, Israel, May 20, 2026 (GLOBE NEWSWIRE) &#8212; PolyPid Ltd. (Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that the Company\u2019s management will participate in investor meetings at the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday, May 28, 2026, at the Depot Renaissance Hotel in Minneapolis, MN. Investors interested in meeting with PolyPid should contact their Craig Hallum representative directly. About PolyPidPolyPid Ltd. (Nasdaq: PYPD) is an innovative biopharmaceutical company dedicated to elevating treatment effectiveness, right where care begins. The Company develops long-acting, controlled-release drugs designed to deliver therapy precisely at the site of care, addressing critical unmet medical needs across &hellip; Continue reading &quot;PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-20T13:24:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference\",\"datePublished\":\"2026-05-20T13:24:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/\"},\"wordCount\":231,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/\",\"name\":\"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=\",\"datePublished\":\"2026-05-20T13:24:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference - Market Newsdesk","og_description":"PETACH TIKVA, Israel, May 20, 2026 (GLOBE NEWSWIRE) &#8212; PolyPid Ltd. (Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that the Company\u2019s management will participate in investor meetings at the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday, May 28, 2026, at the Depot Renaissance Hotel in Minneapolis, MN. Investors interested in meeting with PolyPid should contact their Craig Hallum representative directly. About PolyPidPolyPid Ltd. (Nasdaq: PYPD) is an innovative biopharmaceutical company dedicated to elevating treatment effectiveness, right where care begins. The Company develops long-acting, controlled-release drugs designed to deliver therapy precisely at the site of care, addressing critical unmet medical needs across &hellip; Continue reading \"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-20T13:24:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference","datePublished":"2026-05-20T13:24:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/"},"wordCount":231,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/","name":"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=","datePublished":"2026-05-20T13:24:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjg2OSM3NjEwNzE2IzIwMTY2MTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/965225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=965225"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/965225\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=965225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=965225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=965225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}